Welcome to our dedicated page for Valuence Merger I news (Ticker: VMCA), a resource for investors and traders seeking the latest updates and insights on Valuence Merger I stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Valuence Merger I's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Valuence Merger I's position in the market.
Valuence Merger Corp. I (Nasdaq: VMCA) announced the adjournment of its extraordinary general meeting, initially set for June 3, 2024, to approve an extension for completing a business combination. The meeting will resume at 5:00 p.m. Eastern Time the same day, at White & Case LLP's office in New York. The adjournment aims to give shareholders more time to withdraw previously submitted redemption requests. Shareholders can withdraw their redemptions until the vote on the Extension Amendment Proposal. For withdrawal requests, they should contact Continental Stock Transfer & Trust Company.
Valuence Merger Corp. I (Nasdaq: VMCA) has announced the adjournment of its extraordinary general meeting, initially convened to seek shareholder approval for an extension to complete its initial business combination. The meeting is rescheduled to June 3, 2024, at 10:00 a.m. Eastern Time and will be held at White & Case LLP in New York. Shareholders may withdraw their redemptions until the vote is taken. To reverse a redemption, shareholders should contact Continental Stock Transfer & Trust Company.